Trial intelligence / Profile preview

Colesevelam for Bile Acid Diarrhoea

NCT03876717Phase 4Completed

Start
Oct 2018
Primary completion
Jul 2021
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of colesevelam in bile acid malabsorption (BAM). Started Oct 2018; status: completed.

02

Drugs

colesevelam
03

Conditions

bile acid malabsorption (BAM)

Beyond the preview

Go deeper on NCT03876717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03876717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call